This guideline supersedes guideline KLH-21 version 3.
This guideline is effective as of 15.3.2009
KLH-21 version 4
Reporting adverse reactions to human medicinal products arising from clinical trials
Reporting adverse reactions to human medicinal products arising from clinical trials
This guideline supersedes guideline KLH-21 version 3.
This guideline is effective as of 15.3.2009
2010 © SÚKL. Šrobárova 48, 100 41 Praha 10, +420 272 185 111, posta@sukl
cz.
